NEKTAR THERAPEUTICS Collaboration Agreements
4 Contracts & Agreements
- Amendment No. 2 to Strategic Collaboration Agreement dated as of January 12, 2022, by and between Bristol-M (Filed With SEC on March 1, 2022)
- Amendment No. 1 to Strategic Collaboration Agreement dated as of January 9, 2020, by and between Bristol-Myers Squibb and Company and Nektar Therapeutics (Filed With SEC on February 28, 2020)
- CLINICAL TRIAL COLLABORATION AGREEMENT (Filed With SEC on November 4, 2016)
- COLLABORATION AND LICENSE AGREEMENT by and between DAIICHI SANKYO EUROPE GMBH and NEKTAR THERAPEUTICS DATE: May 30, 2016 (Filed With SEC on August 4, 2016)